RAFARafarma Pharmaceuticals, Inc. (WY)
Price Chart
Loading chart...
About Rafarma Pharmaceuticals, Inc. (WY) (RAFA)
Rafarma Pharmaceuticals, Inc. (WY) (RAFA) is a Drug Manufacturers - Specialty & Generic company headquartered in Draper, UT, United States whose shares trade over-the-counter on the Pink tier.
Rafarma is a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, vaccines and specialty Pharma products in Europe & Asia.
Products and services
Pharmaceutical and Biotech
RAFA key facts
- Ticker symbol
- RAFA
- Market tier
- Pink
- Sector
- Healthcare
- Headquarters
- Draper, UT, United States
- Country of incorporation
- US
- Year of incorporation
- 2012
- Employees
- 700
- Estimated market cap
- $11.57M (as of Apr 11, 2025)
- Shares outstanding
- 87,766,999
- Reporting standard
- Alternative Reporting Standard
- Audit status
- Unaudited
- Fiscal year end
- 12/31
- Latest filing
- Annual Report (Dec 31, 2024)
Rafarma Pharmaceuticals, Inc. (WY) leadership
- Yelyzaveta Babenko — CBO
- Alexey V. Tarasov — Company Secretary
Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with R
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Rafarma Pharmaceuticals, Inc. (WY) (RAFA) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Drug Manufacturers - Specialty & Generic Companies on OTC Markets
Other OTC-traded companies in Drug Manufacturers - Specialty & Generic:
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Company Officers
Social Media
Business Details
Stock Details
Loading modules...